1994
DOI: 10.3109/10731199409117931
|View full text |Cite
|
Sign up to set email alerts
|

Diaspirin Crosslinked Hemoglobin (DCLHbTM)Polymerization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

1995
1995
2013
2013

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 0 publications
1
12
0
Order By: Relevance
“…In fact, PolyhHb was larger in size compared with previously reported PEG‐polymerized Hbs. For example, poly α‐DBBF (diaspirin‐crosslinked Hb polymerized with bis(maleoylglycylamide) PEG) was composed of ∼6.25 Hbs,24, 25 whereas polyDCLHb (diaspirin‐crosslinked Hb polymerized with bis(polysubstituted‐benzenesulfonate ester) PEG) is a heterogeneous HBOC solution composed of Hb multimers 26. The high MW and crosslink density of PolyhHb suggests that infusion of PolyhHb should induce less vasoconstriction and hypertension than either HBOC‐201® or PolyHeme®.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, PolyhHb was larger in size compared with previously reported PEG‐polymerized Hbs. For example, poly α‐DBBF (diaspirin‐crosslinked Hb polymerized with bis(maleoylglycylamide) PEG) was composed of ∼6.25 Hbs,24, 25 whereas polyDCLHb (diaspirin‐crosslinked Hb polymerized with bis(polysubstituted‐benzenesulfonate ester) PEG) is a heterogeneous HBOC solution composed of Hb multimers 26. The high MW and crosslink density of PolyhHb suggests that infusion of PolyhHb should induce less vasoconstriction and hypertension than either HBOC‐201® or PolyHeme®.…”
Section: Discussionmentioning
confidence: 99%
“…a-DBBF and fl-DBBF were produced according to [5]. Polya-DBBF, prepared according to [6], was a kind gift from Baxter Corp., IL, U.S.A. All haemoglobin solutions were chromatographed on a DEAE-Sephadex column to ensure removal of catalase, superoxide dismutase and glutathione. The high level of purity of the haemoglobin solutions was confirmed by the use of SDS/PAGE analysis, isoelectric focusing and HPLC.…”
Section: Experimental Materialsmentioning
confidence: 99%
“…Due to these favourable characteristics, a-DBBF has been developed as a blood substitute [5]. Polymerization of a-DBBF by bis(maleolglycylamide)poly(ethylene glycol) (BMMA-PEG), yielding poly-a-DBBF, offers the added benefit of reduced renal clearance and increased retention in the vascular circulation [6].…”
Section: Introductionmentioning
confidence: 99%
“…Designing low oxygen affinity blood substitutes with enhanced molecular size (dimensions) has been initially attempted by one-step oligomerization platform that introduces intra and intermolecular crosslinking using glutaraldehyde. Chang introduced the oligomerization concept (Chang 1964(Chang , 1971, and since then many new bifunctional crosslinkers have been advanced for the oligomerization of Hb (Bunn et al 1969;Payne 1973;Marini et al 1989;D'Agnillo and Chang 1998;Hai et al 1999;MacDonald and Pepper 1994;Hai et al 1994;Bakker et al 1992;Dellacherie and Vigneron 1991;Zhang and Palmer 2010;Faggiano et al 2010;Tarasov et al 2007;Buehler et al 2006;Scurtu et al 2013;Berbers et al 1991;Adachi et al 1991).…”
Section: Enhancing the Molecular Dimensions Of Hb By Oligomerizationmentioning
confidence: 99%